HRP20182083T1 - Novel combination and use - Google Patents
Novel combination and useInfo
- Publication number
- HRP20182083T1 HRP20182083T1 HRP20182083TT HRP20182083T HRP20182083T1 HR P20182083 T1 HRP20182083 T1 HR P20182083T1 HR P20182083T T HRP20182083T T HR P20182083TT HR P20182083 T HRP20182083 T HR P20182083T HR P20182083 T1 HRP20182083 T1 HR P20182083T1
- Authority
- HR
- Croatia
- Prior art keywords
- novel combination
- novel
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1005318.9A GB201005318D0 (en) | 2010-03-30 | 2010-03-30 | Novel combination |
| GBGB1013211.6A GB201013211D0 (en) | 2010-08-05 | 2010-08-05 | Novel combination |
| PCT/GB2011/050641 WO2011121345A1 (en) | 2010-03-30 | 2011-03-29 | Novel combination and use |
| EP11714379.2A EP2552440B1 (en) | 2010-03-30 | 2011-03-29 | Novel combination and use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20182083T1 true HRP20182083T1 (en) | 2019-03-08 |
Family
ID=43982400
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20182083TT HRP20182083T1 (en) | 2010-03-30 | 2018-12-10 | Novel combination and use |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US9789101B2 (en) |
| EP (1) | EP2552440B1 (en) |
| JP (1) | JP5932762B2 (en) |
| KR (1) | KR20130065649A (en) |
| CN (1) | CN102933212B (en) |
| AU (1) | AU2011234219A1 (en) |
| BR (1) | BR112012024999A2 (en) |
| CA (1) | CA2794570C (en) |
| DK (1) | DK2552440T3 (en) |
| ES (1) | ES2703253T3 (en) |
| HR (1) | HRP20182083T1 (en) |
| HU (1) | HUE041512T2 (en) |
| MX (1) | MX2012011236A (en) |
| PL (1) | PL2552440T3 (en) |
| PT (1) | PT2552440T (en) |
| RU (1) | RU2012146093A (en) |
| SI (1) | SI2552440T1 (en) |
| WO (1) | WO2011121345A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016137352A1 (en) * | 2015-02-26 | 2016-09-01 | Общество С Ограниченной Ответственностью "Консорциум-Пик" | Pharmaceutical composition for treatment of inflammatory ear diseases, method for producing same and method for treatment using said composition |
| GB201518969D0 (en) * | 2015-10-27 | 2015-12-09 | Helperby Therapeutics Ltd | Triple combination |
| EP3703686A4 (en) * | 2017-10-30 | 2021-11-17 | Theracaine LLC | Hydrophobic arenesulfonate salts |
| KR102461715B1 (en) * | 2020-10-12 | 2022-11-02 | 대한민국 | Novel Strain of Penicillium bissettii with Anti-bacterial and Anti-fungal Activity and Uses thereof |
| CN116083290A (en) * | 2022-11-21 | 2023-05-09 | 陕西省微生物研究所 | Preparation method of compound microbial agent suitable for repairing lead-zinc-antibiotic-resistance gene contaminated soil |
| US11926627B1 (en) | 2023-08-30 | 2024-03-12 | King Faisal University | Substituted 7-methyl quinoline derivatives as antitubercular agents |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB843133A (en) * | 1957-07-16 | 1960-08-04 | Biorex Laboratories Ltd | Glycyrrhetinic acid derivatives |
| US4808410A (en) * | 1987-12-16 | 1989-02-28 | Richardson-Vicks Inc. | Pharmaceutical compositions containing dyclonine HC1 and phenol |
| IL95952A0 (en) * | 1989-10-19 | 1991-07-18 | Sterling Drug Inc | Aerosol composition for topical medicament |
| CA2024220A1 (en) * | 1990-08-29 | 1992-03-01 | Don Simmons | Composition containing silver sulfadiazine and benzocaine for use in the treatment of wounds following laser surgery |
| GB9026873D0 (en) * | 1990-12-11 | 1991-01-30 | Beecham Group Plc | Novel compounds |
| PL177592B1 (en) | 1993-10-22 | 1999-12-31 | Smithkline Beecham Corp | Novel composition |
| AU1061100A (en) | 1998-11-09 | 2000-05-29 | St. George's Enterprises Limited | Screening process for antibacterial agents |
| PT1395289E (en) * | 2000-06-08 | 2011-03-16 | Sang Dr Christine | Treatment of neuropathic pain with a n-methyl-d-aspartate (nmda) receptor antagonists |
| US6974585B2 (en) | 2001-08-01 | 2005-12-13 | Medlogic Global Limited | Durable multi-component antibiotic formulation for topical use |
| JP3876232B2 (en) * | 2003-04-18 | 2007-01-31 | 有限会社ユーワ商事 | Ophthalmic preparations, eye drops, artificial tears, contact lens care products, eye washes, and eye ointments |
| MXPA06001552A (en) | 2003-08-08 | 2006-09-04 | Ulysses Pharmaceutical Product | Halogenated quinazolinyl nitrofurans as antibacterial agents. |
| WO2005119899A2 (en) * | 2004-05-13 | 2005-12-15 | University Of Virginia Patent Foundation | Use of lacritin in promoting ocular cell survival |
| KR20070091613A (en) | 2004-11-08 | 2007-09-11 | 그렌마크 파머수티칼스 엘티디. | Topical pharmaceutical compositions containing an antiacne compound and antibiotic compound |
| GB0522715D0 (en) * | 2005-11-08 | 2005-12-14 | Helperby Therapeutics Ltd | New use |
| US7767217B2 (en) * | 2006-03-14 | 2010-08-03 | Foresight Biotherapeutics | Ophthalmic compositions comprising povidone-iodine |
| GB0705915D0 (en) * | 2007-03-28 | 2007-05-09 | Helperby Therapeutics Ltd | New use |
| DK2182950T3 (en) * | 2007-05-17 | 2017-11-06 | Helperby Therapeutics Ltd | USE OF 4- (PYRROLIDIN-1-YL) QUINOLINE COMPOUNDS TO KILL CLINIC LATENT MICROORGANISMS |
| US9248093B2 (en) * | 2009-06-11 | 2016-02-02 | Becton, Dickinson And Company | Catheter locking solution having antimicrobial and anticoagulation properties |
-
2011
- 2011-03-29 BR BR112012024999A patent/BR112012024999A2/en not_active IP Right Cessation
- 2011-03-29 PL PL11714379T patent/PL2552440T3/en unknown
- 2011-03-29 CN CN201180026672.4A patent/CN102933212B/en not_active Expired - Fee Related
- 2011-03-29 KR KR1020127028381A patent/KR20130065649A/en not_active Application Discontinuation
- 2011-03-29 PT PT11714379T patent/PT2552440T/en unknown
- 2011-03-29 US US13/624,488 patent/US9789101B2/en not_active Expired - Fee Related
- 2011-03-29 SI SI201131637T patent/SI2552440T1/en unknown
- 2011-03-29 AU AU2011234219A patent/AU2011234219A1/en not_active Abandoned
- 2011-03-29 MX MX2012011236A patent/MX2012011236A/en not_active Application Discontinuation
- 2011-03-29 CA CA2794570A patent/CA2794570C/en not_active Expired - Fee Related
- 2011-03-29 ES ES11714379T patent/ES2703253T3/en active Active
- 2011-03-29 WO PCT/GB2011/050641 patent/WO2011121345A1/en active Application Filing
- 2011-03-29 DK DK11714379.2T patent/DK2552440T3/en active
- 2011-03-29 EP EP11714379.2A patent/EP2552440B1/en not_active Not-in-force
- 2011-03-29 HU HUE11714379A patent/HUE041512T2/en unknown
- 2011-03-29 JP JP2013501944A patent/JP5932762B2/en not_active Expired - Fee Related
- 2011-03-29 RU RU2012146093/15A patent/RU2012146093A/en not_active Application Discontinuation
-
2018
- 2018-12-10 HR HRP20182083TT patent/HRP20182083T1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2703253T3 (en) | 2019-03-07 |
| CA2794570A1 (en) | 2011-10-06 |
| US9789101B2 (en) | 2017-10-17 |
| CN102933212B (en) | 2015-07-22 |
| PT2552440T (en) | 2019-01-10 |
| AU2011234219A1 (en) | 2012-10-18 |
| DK2552440T3 (en) | 2019-01-21 |
| KR20130065649A (en) | 2013-06-19 |
| RU2012146093A (en) | 2014-05-10 |
| CN102933212A (en) | 2013-02-13 |
| JP2013523707A (en) | 2013-06-17 |
| US20130096151A1 (en) | 2013-04-18 |
| SI2552440T1 (en) | 2019-03-29 |
| HUE041512T2 (en) | 2019-05-28 |
| CA2794570C (en) | 2018-03-06 |
| MX2012011236A (en) | 2013-03-05 |
| EP2552440A1 (en) | 2013-02-06 |
| WO2011121345A1 (en) | 2011-10-06 |
| JP5932762B2 (en) | 2016-06-15 |
| BR112012024999A2 (en) | 2016-07-12 |
| EP2552440B1 (en) | 2018-10-10 |
| PL2552440T3 (en) | 2019-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS2100032I1 (en) | Substituted 5-fluoro-1h-pyrazolopyridines and use thereof | |
| HK1187049A1 (en) | Bisaryl-bonded aryltriazolones and use thereof | |
| HK1206004A1 (en) | Ingenol-3-acylates iii and ingenol-3-carbamates -3- iii -3- | |
| ZA201208173B (en) | Peptices and their use | |
| EP2552953A4 (en) | Frizzled-binding agents and uses thereof | |
| HRP20182083T1 (en) | Novel combination and use | |
| EP2558137A4 (en) | Methods and combination | |
| ZA201303773B (en) | Compounds and their use | |
| EP2575453A4 (en) | Oligo-benzamide compounds and their use | |
| EP2608785A4 (en) | Lipomacrocycles and uses thereof | |
| EP2529013A4 (en) | Novel -glucosidase and uses thereof | |
| EP2615094A4 (en) | Sesterterpene compounds and use thereof | |
| EP2638160A4 (en) | Nuclions and ribocapsids | |
| GB201020848D0 (en) | Compounds and their use | |
| GB201018028D0 (en) | Compounds and their use | |
| GB201017822D0 (en) | Compounds and their use | |
| GB201005511D0 (en) | Compounds and their use | |
| GB201002337D0 (en) | Compounds and their use | |
| GB201000309D0 (en) | Compounds and their use | |
| GB201000307D0 (en) | Compounds and their use | |
| GB201000305D0 (en) | Compounds and their use | |
| GB201000308D0 (en) | Compounds and their use | |
| EP2567956A4 (en) | Novel prenylarene compound and use thereof | |
| GB201001670D0 (en) | Use | |
| GB201014319D0 (en) | Compounds and uses thereof |